marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q2
added 08-07-2024
Relmada Therapeutics Cash Flow 2011-2024 | RLMD
Annual Cash Flow Relmada Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-51.7 M | -104 M | -91.9 M | -27.8 M | -12.1 M | -6 M | -6.47 M | -13.1 M | -16.2 M | - | -2.24 M | -1.58 M | - |
Depreciation & Amortization |
- | - | 1.26 K | 3.75 K | 4.36 K | 2.63 K | 85.3 K | 54.8 K | 9.26 K | - | 373 | - | - |
Accounts Payables |
3.51 M | 5.26 M | 11.2 M | 8.35 M | 523 K | 765 K | 530 K | 1.26 M | 835 K | 746 K | 180 K | - | - |
Accounts Receivables |
- | 512 K | - | - | - | - | - | - | - | - | - | 566 K | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Relmada Therapeutics
| 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | -13 M | - | - | - | -16.5 M | - | -67.9 M | -41.1 M | -19.4 M | - | -54.2 M | -33.3 M | -16.1 M | - | -20.9 M | -8.38 M | -3.42 M | - | -2.53 M | -5.68 M | -2.01 M | - | -1.67 M | -4.82 M | -1.67 M | - | -979 K | -2.11 M | - | - | -2.14 M | -3.6 M | - | - | -3.22 M | -6.69 M | -3.22 M | - | -2.32 M | -7.31 M | -2.32 M | -9.12 K | -409 K | -1.44 K | -35.5 K | 1.5 K | -4.22 K | -2.24 K | - | - | - | - | - |
Depreciation & Amortization |
- | - | - | - | - | - | - | - | - | - | - | 1.26 K | 1.26 K | 806 | - | 2.93 K | 2.08 K | 1.05 K | - | 1.1 K | 2.16 K | 1.08 K | - | 1.4 K | 2.71 K | 1.4 K | - | 548 | 1.13 K | 548 | - | 20.2 K | 43.7 K | 20.2 K | - | 2.95 K | 5.91 K | 2.95 K | - | 3.59 K | 3.5 K | 3.59 K | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Payables |
4.17 M | 5.19 M | 3.51 M | 2.86 M | 4.85 M | 4.42 M | 5.26 M | 10.4 M | 7.54 M | 10.7 M | 11.2 M | 12.7 M | 10.5 M | 8.08 M | 8.35 M | 8.35 M | 8.35 M | 8.35 M | 523 K | 523 K | 523 K | 523 K | 359 K | 1.02 M | 765 K | 765 K | 286 K | 351 K | 530 K | 530 K | 307 K | 672 K | 1.26 M | 1.26 M | 1.69 M | 1.15 M | 835 K | 835 K | 970 K | 625 K | 746 K | 746 K | 180 K | 33.7 K | 25.8 K | 40.3 K | 237 K | 7 K | 7 K | - | - | - | - | - |
Accounts Receivables |
- | - | - | - | - | - | 512 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 566 K | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency